Laboratorios Richmond SACIF

Laboratorios Richmond SACIF ROA

The Return on Assets (ROA) of Laboratorios Richmond SACIF (RICH.BA) as of Nov 21, 2026 is 9.17 %. In the previous year, Return on Assets (ROA) was -7.00 % — a change of -230.85% (higher).

ROA

9.17 %

YoY

-230.85%

Last updated:

In 2024, Laboratorios Richmond SACIF's return on assets (ROA) was 9.17 %, a -230.85% increase from the -7.00 % ROA in the previous year.

The Laboratorios Richmond SACIF ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2017
1.89 ARS
Jan 1, 2018
-7.97 ARS
Jan 1, 2019
2.27 ARS
Jan 1, 2020
5.67 ARS
Jan 1, 2021
2.30 ARS
Jan 1, 2022
0.40 ARS
Jan 1, 2023
-7.00 ARS
Jan 1, 2024
9.17 ARS
The Laboratorios Richmond SACIF ROA history
YEARROAYoY
9.17 %-230.85%
-7.00 %-1,845.32%
0.40 %-82.57%
2.30 %-59.42%
5.67 %+150.16%
2.27 %-128.45%
-7.97 %-521.67%
1.89 %-82.83%
11.01 %+906.69%
1.09 %-34.80%
1.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

ROA Details

Understanding Laboratorios Richmond SACIF's Return on Assets (ROA)

Laboratorios Richmond SACIF's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Laboratorios Richmond SACIF's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Laboratorios Richmond SACIF's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Laboratorios Richmond SACIF’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Return on Assets (ROA) of Laboratorios Richmond SACIF is 9.17 % in 2024.

Return on Assets (ROA) of Laboratorios Richmond SACIF changed from -7.00 % to 9.17 %, representing a -230.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Laboratorios Richmond SACIF with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF